Advanced Search
QI Feng, GAO Yan-feng, SUN Zhan-qiang, HU Hong-min, CHEN Li-xiang, QI Yuan-ming. Identification and Optimization of HLA-A2 Restricted COX-2 Derived Antigen Peptides[J]. Cancer Research on Prevention and Treatment, 2008, 35(07): 460-463. DOI: 10.3971/j.issn.1000-8578.1481
Citation: QI Feng, GAO Yan-feng, SUN Zhan-qiang, HU Hong-min, CHEN Li-xiang, QI Yuan-ming. Identification and Optimization of HLA-A2 Restricted COX-2 Derived Antigen Peptides[J]. Cancer Research on Prevention and Treatment, 2008, 35(07): 460-463. DOI: 10.3971/j.issn.1000-8578.1481

Identification and Optimization of HLA-A2 Restricted COX-2 Derived Antigen Peptides

More Information
  • Corresponding author:

    QI Yuan2ming

  • Received Date: December 31, 2006
  • Revised Date: January 23, 2008
  • 目的 筛选和鉴定食管癌广泛高表达蛋白COX-2的HLA-A2限制性CTL表位。方法 运用生物信息学的方法,以SYFPEITHI法初步预测,结合MHCPred 2.0和NetChop3.0 Server在线分析,设计出五条新的抗原肽。通过标准Fmoc固相合成法合成抗原肽,以流式细胞仪对其与HLA-A2分子的结合力和稳定性进行分析,并对结合力较低的P66(FI<0.5)的原始序列进行改造,将其序列第一位的苯丙氨酸替换成酪氨酸(P66Y1),以MTT实验检测抗原肽诱导的特异性CTL对肿瘤细胞的杀伤作用。 结果 P321对HLA-A2分子有较高的结合力(FI=1.93),同时P66Y1与HLA-A2分子的结合力显著增强(FI=1.48),并且它们与HLA-A2分子的稳定性较好(DC50>2h)。P321和P66Y1对表达COX-2的EC-9706、EC-1的杀伤率分别明显高于P66。结论 源于食管癌广泛高表达抗原COX-2的抗原肽P321和P66Y1能分别有效激发HLA-A2限制性CTL的免疫应答并杀伤肿瘤细胞。
  • Related Articles

    [1]Wang Jingyuan, Ma Xiumei. Expression and Biological Significance of cPLA2 and COX-2 in Lung Cancer Tissues[J]. Cancer Research on Prevention and Treatment, 2012, 39(03): 285-288. DOI: 10.3971/j.issn.1000-8578.2012.03.010
    [2]Wang Xiaoli, Gong Xingmu. Expression of COX-2 and Trx-1 in Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(02): 166-168. DOI: 10.3971/j.issn.1000-8578.2012.02.012
    [4]TIAN Feng, WANG Tian-you, CHANG Dong, GONG Min, TONG Yu-jun. Expression of COX-2 and survivin in Esophageal Carcinoma and Relationship with Prognosis[J]. Cancer Research on Prevention and Treatment, 2009, 36(03): 203-206. DOI: 10.3971/j.issn.1000-8578.2009.03.010
    [5]ZHU Zheng-peng, JIA Guo-feng, YANG Wei-rong, SHEN Qin, MA Jian-bo, LI Kai, XIE Yong-hui. Expressions of Glut-1 and COX-2 in Endometrial Adenocarcinoma and Precancerous Lesion[J]. Cancer Research on Prevention and Treatment, 2008, 35(04): 266-268. DOI: 10.3971/j.issn.1000-8578.1537
    [6]WEI Liang-hong, LIN Yao-guang. Expression of COX-2 and BFGF, BFGFR in Carcinoma of Colon and Rectumand the Relationship between COX-2 and BFGF, BFGFR Expression and Dukes Stages and Lymphnode Metastasis[J]. Cancer Research on Prevention and Treatment, 2007, 34(08): 600-602. DOI: 10.3971/j.issn.1000-8578.1627
    [7]SUN Zhan-qiang, LI Yong-xin, LOU Hui-ping, LI Jing-jing, CHEN Li-xiang, QI Yuan-ming. Prediction of HLA-A2/3 Restricted Cytototxic T Lymphocyte Epitopes in Hyper-expressed Antigens in Esophageal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2007, 34(06): 412-415. DOI: 10.3971/j.issn.1000-8578.3219
    [8]SONG Wei-qing, LIU Yu, WEI Jin-ying, ZHOU Bao-jun, HAN Cai-li, CHEN Yi. Role of p38MAPK in Apoptosis of Colon Cancer Cells and Its Relationship with COX-2[J]. Cancer Research on Prevention and Treatment, 2007, 34(05): 359-362. DOI: 10.3971/j.issn.1000-8578.1664
    [9]CAI Rui-xia, SHENG Xia, YUAN Zhi-hao, YE Zeng-qiang. Expression of CD105, COX-2 and VEGF and Their Relationship with Angiogenesis in Colorectal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2007, 34(02): 125-127. DOI: 10.3971/j.issn.1000-8578.585
    [10]WANG Yang, LIN Cong-yao, ZHOU Xia. Expression of β-catenin in Human Colorectal Carcinoma and Its Relationship to Expression of COX-2 with VEGF[J]. Cancer Research on Prevention and Treatment, 2006, 33(01): 20-22. DOI: 10.3971/j.issn.1000-8578.1564

Catalog

    Corresponding author: QI Yuan-ming

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (2788) PDF downloads (642) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return